scholarly journals A patient with end-stage renal disease who recovered from coronavirus disease 2019 then received a kidney transplant

2021 ◽  
pp. 101395
Author(s):  
Tianyu Wang ◽  
Tao Qiu ◽  
Ming Wang ◽  
Yan Yuan ◽  
Zhongbao Chen ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

Racial Differences in Access to the Kidney Transplant Waiting List for Children and Adolescents With End-Stage Renal Disease

PEDIATRICS ◽  
2000 ◽  
Vol 106 (4) ◽  
pp. 756-761 ◽  
Author(s):  
S. L. Furth ◽  
P. P. Garg ◽  
A. M. Neu ◽  
W. Hwang ◽  
B. A. Fivush ◽  
...  
Keyword(s):  
Renal Disease ◽  
Children And Adolescents ◽  
Kidney Transplant ◽  
Racial Differences ◽  
End Stage Renal Disease ◽  
Waiting List ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ashwin Radhakrishnan ◽  
Luke C. Pickup ◽  
Anna M. Price ◽  
Jonathan P. Law ◽  
Kirsty C. McGee ◽  
...  
Keyword(s):  
Confidence Interval ◽  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Microvascular Dysfunction ◽  
Left Ventricular ◽  
Coronary Microvascular Dysfunction ◽  
Transplant Candidates ◽  
Stage Renal Disease ◽  
End Stage

Abstract Background Coronary microvascular dysfunction (CMD) is common in end-stage renal disease (ESRD) and is an adverse prognostic marker. Coronary flow velocity reserve (CFVR) is a measure of coronary microvascular function and can be assessed using Doppler echocardiography. Reduced CFVR in ESRD has been attributed to factors such as diabetes, hypertension and left ventricular hypertrophy. The contributory role of other mediators important in the development of cardiovascular disease in ESRD has not been studied. The aim of this study was to examine the prevalence of CMD in a cohort of kidney transplant candidates and to look for associations of CMD with markers of anaemia, bone mineral metabolism and chronic inflammation. Methods Twenty-two kidney transplant candidates with ESRD were studied with myocardial contrast echocardiography, Doppler CFVR assessment and serum multiplex immunoassay analysis. Individuals with diabetes, uncontrolled hypertension or ischaemic heart disease were excluded. Results 7/22 subjects had CMD (defined as CFVR < 2). Demographic, laboratory and echocardiographic parameters and serum biomarkers were similar between subjects with and without CMD. Subjects with CMD had significantly lower haemoglobin than subjects without CMD (102 g/L ± 12 vs. 117 g/L ± 11, p = 0.008). There was a positive correlation between haemoglobin and CFVR (r = 0.7, p = 0.001). Similar results were seen for haematocrit. In regression analyses, haemoglobin was an independent predictor of CFVR (β = 0.041 95% confidence interval 0.012–0.071, p = 0.009) and of CFVR < 2 (odds ratio 0.85 95% confidence interval 0.74–0.98, p = 0.022). Conclusions Among kidney transplant candidates with ESRD, there is a high prevalence of CMD, despite the absence of traditional risk factors. Anaemia may be a potential driver of microvascular dysfunction in this population and requires further investigation.

Diabetes as the Cause of End-Stage Renal Disease Affects the Pattern of Post Kidney Transplant Rehospitalizations

2007 ◽  
Vol 39 (4) ◽  
pp. 966-969 ◽  
Author(s):  
M. Ramezani ◽  
K. Ghoddousi ◽  
M. Hashemi ◽  
H.-R. Khoddami-Vishte ◽  
S. Fatemi-Zadeh ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

Impact of First Dialysis Modality on Outcome of Patients Contraindicated for Kidney Transplant

2006 ◽  
Vol 26 (2) ◽  
pp. 231-239 ◽  
Author(s):  
Luc Frimat ◽  
Pierre-Yves Durand ◽  
Carole Loos–Ayav ◽  
Emmanuel Villar ◽  
Victor Panescu ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Kidney Disease ◽  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Role Limitation ◽  
Stage Renal Disease ◽  
End Stage ◽  
Incident Cases

Background We compared, in patients contraindicated for kidney transplant, outcomes between those patients who were only on hemodialysis (HD) and those who were given peritoneal dialysis (PD) as first renal replacement therapy (RRT). Design Prospective, population-based cohort study of incident cases of end-stage renal disease between June 1997 and June 1999. Setting A network of dialysis care: NEPHROLOR, that is, all the renal units in Lorraine, one of the 22 French administrative regions (population over 2.3 million people). Participants 387 patients were contraindicated for kidney transplant during the first 2 years of RRT: 284 were on HD, 103 on PD. Mean age was 67.6 ± 11.3 years for HD patients and 70.8 ± 11.4 years for PD patients ( p = 0.015). Main Outcome Measures Mortality until June 2003, hospitalization over the 2 first years of RRT, and Kidney Disease and Quality of Life Short Form (KDQOL-SF) 6 and 12 months after initiation of RRT. Results HD patients were more likely to die from cardiac or cerebrovascular causes, PD from cachexia or withdrawal from dialysis. Whatever mode of RRT, the unadjusted 2-year and 5-year survival rates were similar ( p = 0.98). The rate of total duration of hospital stay per month of RRT was similar in HD and PD groups: 2.7 ± 4.5 and 2.9 ± 4.2 days respectively ( p = 0.7). PD was associated with better quality of life than HD. The dimensions Role limitation due to emotional function, Burden of kidney disease, and Role limitation due to physical function ranked first, second, and third for PD. Conclusion In Lorraine, end-stage renal disease patients who were given PD as first-line RRT had no excess of death risk or hospitalizations, and better quality of life the first year of RRT.

Burden of End-Stage Renal Disease and Access to Kidney Transplant in the African American and Hispanic/Latino Population

2019 ◽  
Vol 229 (4) ◽  
pp. e17
Author(s):  
Pablo Serrano Rodríguez ◽  
Brian G. Orleans ◽  
Paula D. Strassle ◽  
Emily Newton ◽  
Chirag S. Desai
Keyword(s):  
African American ◽  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Latino Population ◽  
Stage Renal Disease ◽  
End Stage

576 RENAL CELL CARCINOMA IN END-STAGE RENAL DISEASE: ACCORDING TO THE KIDNEY TRANSPLANT AND DIALYSIS

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Hyung Ho Lee ◽  
Ho Song Yu ◽  
Woo Jin Bang ◽  
Woong Kyu Han ◽  
Sung Jun Hong
Keyword(s):  
Renal Cell Carcinoma ◽  
Renal Disease ◽  
Cell Carcinoma ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Renal Cell ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Duration of end-stage renal disease and kidney transplant outcome

2004 ◽  
Vol 20 (1) ◽  
pp. 167-175 ◽  
Author(s):  
A. Goldfarb-Rumyantzev ◽  
J. F. Hurdle ◽  
J. Scandling ◽  
Z. Wang ◽  
B. Baird ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Transplant Outcome ◽  
Stage Renal Disease ◽  
End Stage

Simultaneous pancreas-kidney transplant compared with kidney transplant in Type I diabetic patients with end-stage renal disease

2001 ◽  
Vol 33 (7-8) ◽  
pp. 3494-3495 ◽  
Author(s):  
R. Pérez ◽  
M.D. Navarro ◽  
D. del Castillo ◽  
R. Santamarı́a ◽  
J. Padillo ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Diabetic Patients ◽  
Type I ◽  
Simultaneous Pancreas Kidney ◽  
Stage Renal Disease ◽  
End Stage

APOL1 -Associated End-Stage Renal Disease in a Living Kidney Transplant Donor

2016 ◽  
Vol 16 (12) ◽  
pp. 3568-3572 ◽  
Author(s):  
N. A. Zwang ◽  
A. Shetty ◽  
N. Sustento-Reodica ◽  
E. J. Gordon ◽  
J. Leventhal ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
Kidney Transplant Donor

scholarly journals Risks and Benefits of Kidney Transplantation during the COVID Pandemic: Transplant or Not Transplant?

Kidney360 ◽  
2021 ◽  
pp. 10.34067/KID.0002532021
Author(s):  
Maria Ajaimy ◽  
Luz Liriano-Ward ◽  
Jay A Graham ◽  
Enver Akalin
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Donor Selection ◽  
Waiting List ◽  
Morbidity And Mortality ◽  
Kidney Transplant Recipients ◽  
Risks And Benefits ◽  
Stage Renal Disease ◽  
End Stage

COVID-19 disease has significantly affected the transplant community by leading to decreased transplant activity and increased waiting list time. As expected, COVID-19 causes substantial mortality in both end-stage renal disease and kidney transplant populations. This is due to underlying chronic kidney disease and a high prevalence of comorbid conditions such as diabetes mellitus, hypertension, and cardiovascular disease in this group. Transplant programs have faced the difficult decision of weighing the risks and benefits of transplantation during the pandemic. On one hand there is a risk of COVID-19 exposure leading to infection while patients are on maximum immunosuppression. Alternatively, there are risks of delaying transplantation, which will increase waitlist-time and may lead to waitlist-associated morbidity and mortality. Cautious and thoughtful selection of both the recipient's and donor's post-transplant management is required during the pandemic to mitigate the risk of morbidity and mortality associated with COVID-19. In this review article we aimed to discuss previous publications related to clinical outcomes of COVID-19 disease in kidney transplant recipients, end-stage renal disease patients on dialysis or on the transplant waiting-list and precautions transplant centers should take in decision making for recipient and donor selection and immunosuppressive management during the pandemic. Nevertheless, transplantation in this milieu does seem to be the correct decision with a careful patient and donor selection with safeguard protocols for infection prevention. Each center should do risk assessment based on their patient's age and medical comorbidities, waitlist time, degree of sensitization, cold ischemia time, status of vaccination, and severity of pandemic in their region.

Sign in / Sign up

Export Citation Format

Share Document